Ignite Creation Date:
2024-05-06 @ 7:33 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06058182
Status:
RECRUITING
Last Update Posted:
2023-10-06
First Post:
2023-02-15
Brief Title:
RNA as Prognostic Biomarkers in Patients With Acute Coronary Syndrome
Sponsor:
IRCCS Policlinico S Donato
Organization:
IRCCS Policlinico S Donato
Study Overview
Official Title:
RNA as Prognostic Biomarkers in Patients With Acute Coronary Syndrome
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RNAacs
Brief Summary:
Identify circulating protein-coding mRNAs or non-coding ncRNAs transcripts ACS_signature predictive of ventricular dysfunction in ACS patients undergoing PCI
Detailed Description:
Perform an observational prospective study involving the evaluation of circulating biomarkers predictive of ventricular dysfunction FE 45 in patients with ACS
In particular will be to verify whether there are circulating transcripts in peripheral blood coding or not for proteins mRNAs or ncRNAs modulated differently in patients with ACS ACS_signature undergoing PCI distinguished on the basis of evolution towards ventricular dysfunction The study will be based on whole genome transcriptomic analysis
In particular will be to verify whether there are circulating transcripts in peripheral blood coding or not for proteins mRNAs or ncRNAs modulated differently in patients with ACS ACS_signature undergoing PCI distinguished on the basis of evolution towards ventricular dysfunction The study will be based on whole genome transcriptomic analysis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None